{"id":"iomeglamic-acid","rwe":[{"pmid":"2594830","year":"1989","title":"[Improvement of the solubility behavior of problem drugs. 20. The effect of pharmaceutical excipients on the wetability of iomeglamic acid].","finding":"","journal":"Die Pharmazie","studyType":"Clinical Study"},{"pmid":"3380871","year":"1988","title":"[Improvement of the solubility of problem drugs. 18. Iomeglamic acid-PVA effervescent powder].","finding":"","journal":"Die Pharmazie","studyType":"Clinical Study"},{"pmid":"3380870","year":"1988","title":"[Improvement of the solubility of problem drugs. 17. Processing of iomeglamic acid/methylcellulose coprecipitates in tablets].","finding":"","journal":"Die Pharmazie","studyType":"Clinical Study"},{"pmid":"3432342","year":"1987","title":"[Improvement of the solubility of problem drugs. 15. X-ray diffraction of iomeglamic acid-methylcellulose (MH 300)-PEG 6000-coprecipitate].","finding":"","journal":"Die Pharmazie","studyType":"Clinical Study"},{"pmid":"3432340","year":"1987","title":"[Improvement of the solubility of problem drugs. 15. Alteration of iomeglamic acid-methylcellulose (MH 300)-PEG 6000 coprecipitates].","finding":"","journal":"Die Pharmazie","studyType":"Clinical Study"}],"tags":[{"label":"iomeglamic acid","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"falignost","offLabel":[],"synonyms":["iomeglamic acid","falignost","iomeglamis acid"],"timeline":[],"approvals":[],"brandName":"Falignost","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"iomeglamic acid","explanation":"The mechanism of action for iomeglamic acid is not available, but in general, small molecule drugs like iomeglamic acid work by interacting with specific biological targets, such as proteins or receptors, to produce a therapeutic effect. This interaction can alter the activity of the target, leading to changes in the body's physiological processes. However, without more information about iomeglamic acid, it is impossible to provide a detailed explanation of its mechanism of action.","oneSentence":"Unfortunately, the mechanism of action for iomeglamic acid is not available.","technicalDetail":"Unfortunately, the technical details of iomeglamic acid's mechanism of action are not available."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3307","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=IOMEGLAMIC ACID","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T13:59:23.940987","biosimilars":[],"competitors":[],"genericName":"iomeglamic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"S4H62451TO","CHEBI":"CHEBI:135850","INN_ID":"3115","UMLSCUI":"C0063809","ChEMBL_ID":"CHEMBL2104342","PUBCHEM_CID":"65721","MESH_SUPPLEMENTAL_RECORD_UI":"C002060"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":16,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"1989 Aug","pmid":"2594830","title":"[Improvement of the solubility behavior of problem drugs. 20. The effect of pharmaceutical excipients on the wetability of iomeglamic acid].","journal":"Die Pharmazie"},{"date":"1988 Mar","pmid":"3380871","title":"[Improvement of the solubility of problem drugs. 18. Iomeglamic acid-PVA effervescent powder].","journal":"Die Pharmazie"},{"date":"1988 Mar","pmid":"3380870","title":"[Improvement of the solubility of problem drugs. 17. Processing of iomeglamic acid/methylcellulose coprecipitates in tablets].","journal":"Die Pharmazie"},{"date":"1987 Aug","pmid":"3432342","title":"[Improvement of the solubility of problem drugs. 15. X-ray diffraction of iomeglamic acid-methylcellulose (MH 300)-PEG 6000-coprecipitate].","journal":"Die Pharmazie"},{"date":"1987 Aug","pmid":"3432340","title":"[Improvement of the solubility of problem drugs. 15. Alteration of iomeglamic acid-methylcellulose (MH 300)-PEG 6000 coprecipitates].","journal":"Die Pharmazie"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Iomeglamic acid is a small molecule drug of the iomeglamic acid class, but specific details about its development, commercial status, and approved indications are not available. As a result, there is limited information about its target, half-life, bioavailability, and generic manufacturers. The mechanism of action and key safety considerations for iomeglamic acid are also unknown. Further research is needed to understand its pharmacological properties and clinical applications. Unfortunately, without more information, it is challenging to provide a comprehensive summary of this drug.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}